2012-2010年 研究業績
2019- 2018-2016 2015-2013 2009-2007 2006-2004 2003-2001 2000以前
1) Noto D, Takahashi K, Miyake S, Yamada M: In vitro differentiation of lineage-negative bone marrow cells into microglia-like cells. Eur J Neurosci 31:1155-63, 2010
2) Sakuishi K, Miyake S,
Yamamura T: Role of NKT cells in multiple sclerosis: In a quest to
understand and overcome their highly efficient double edged swords. Molecular Basis of Multiple Scoerosis. The Immune System Series "Results and Problems in Cell Differentiation" Gramm U, ed, Springer-Verlag, Heidelberg, 51:127-147, 2010
3) Chihara N, Aranami T, Sato W, Miyazaki Y, Miyake S,
Okamoto T, Ogawa M, Toda T, Yamamura T: Interleukin 6 signaling
promotes anti-aquaporin 4 autoantibody production from plasmablasts in
neuromyelitis optica. Proc Natl Acad Sci USA 108(9):3701-3706, 2011
4) Miyazaki Y, Miyake S,
Chiba A, Lantz O, Yamamura T. Mucosal-associated invariant T cells
regulate Th1 response Int Immunol. 2011 Sep;23(9):529-35 in multiple
sclerosis. Int Immunol 23(9):529-535, 2011
5) Chiba A, Tajima R, Tomi C, Miyazaki Y, Yamamura T, Miyake S: Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis Arthritis Rheum. 2012 Jan;64(1):153-61
6) Ichikawa D, Mizuno M, Yamamura T, Miyake S.:
Gene related to anergy in lymphocytes (GRAIL) regulates cytoskeletal
reorganization through ubiquitination and degradation of Arp2/3-5 and
coronin 1A. J Biol Chem. 286(50):43465-74, 2011
7) Miyake S.: Mind over cytokines: Crosstalk and regulation between the neuroendocrine and immune systems, Clinical and Experimental Neuroimmunology, Article first published online: 8 JUL 2011
8) Chiba A, Mizuno M, Tomi C, Tajima R, Alloza I, di Penta A, Yamamura T, Vandenbroeck K, Miyake S: A 4-trifluoromethyl analogue of celecoxib inhibits arthritis by suppressing innate immune cell activation.Arthritis Res Ther. 2012 Jan 17;14(1):R9
9) Toba T, Murata K, Futamura J, Nakanishi K, Takahashi B, Takemoto N,
Tomino M, Nakatsuka T, Seiichi Imajo S, Goto M, Yamamura T, Miyake S,
Annoura H: Synthesis and biological evaluation of truncated
α-galactosylceramide derivatives focusing on cytokine induction
profile. Bioorg & Medic Chem 20:2850-2859, 2012
10) Yamamura T, Miyake S: Editorial. B-cell-directed therapy. Which B cells should be targeted and how? Immunother 4:1-3, 2012
11) Araki M, Aranami T, Matsuoka T, Nakamura M, Miyake S,
Yamamura T.: Clinical improvement in a patient with neuromyelitis
optica following therapy with the anti-IL-6 receptor monoclonal
antibody tocilizumab. Modern Rheumatol published online, (11 July 2012)
12) Yamamura T, Miyake S. : B-cell-directed therapy: which B cells should be targeted and how? Immunotherapy 4: 455-457, 2012
13) Chiba A, Tajima R, Tomi C, Miyazaki Y, Yamamura T, Miyake S. : Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis. Arthritis Rheum 64: 153-161, 2012
14) Sato W, Tomita A, Ichikawa D, Lin Y, Kishida H, Miyake S,
Ogawa M, Okamoto T, Murata M, Kuroiwa Y, Aranami T, Yamamura T
CCR2+CCR5+ T cells produce matrix metalloproteinase-p and osteopontin
in the pathogenesis of multiple sclerosis. J Immunol 189: 5057-5065, 2012
順天堂大学医学部 順天堂大学大学院医学研究科
〒113-8421 東京都文京区本郷2-1-1 7号館（A棟）6階 6Nスタッフルーム
電話：03-5802-1044／1045 FAX：03-3813-0421